Effects of insulin-like growth factor-1 and AZT in cats experimentally infected with FIV

Feline Practice

Volumn 25, Issue 4, 1997, Pages 23-31

  Gregory, C R ^a   Barlough, J E ^a   Clark, R ^b   Griffey, S M ^a   Patz, J D ^a   Jardieu, P ^b   Pedersen, N C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25744448438     PISSN: 10576614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Torten M, Franchini M, Barlough JE, et al: Progressive Immune Dysfunction in Cats Experimentally Infected With Feline Immunodeficiency Virus. J Virology 65:2225-2230, 1991.
2. Phillips LS, Harp JB, Goldstein S, et al: Regulation and Action of Insulin-Like Growth Factors at the Cellular Level. Proc Nutritional Soc 49:451-458, 1990.
3. Froesch ER, Guler HP, Ernst M, et al: Growth Promoting and Hypoglycemic Effects of Human Recombinant IGF-1 in vivo in the Context of in vitro Actions of IGF-1, In: Growth Hormone Basic and Clinical Aspects. Ed by O Isaksson, C Binder, K Hall, B Hokfell. Elsevier, Amsterdam, 1987. pp 321-336.
4. Guler HP, Zapf J, Scheiwiller E, et al: Recombinant Human Insulin-Like Growth Factor 1 Stimulates Growth and Has Distinct Effects on Organ Size in Hypophysectomized Rats. Proc Natl Acad Sci 85:4889-4893, 1988.
5. Binz K, Joller P, Froesch P, et al: Repopulation of the Atrophied Thymus in Diabetic Rats by insulin-Like Growth Factor 1. Proc Natl Acad Sci 87:3690-3694, 1990.
6. Clark R, Strasser J, McCabe S, et al: Insulin-Like Growth Factor-1 Stimulation of Lymphopoiesis. J Clin Invest 92:540-548, 1993.
7. North TW, North GLT, Pedersen NC: Feline Immunodeficiency Virus, a Model for Reverse Transcriptase-Targeted Chemotherapy for Acquired Immune Deficiency Syndrome. Antimicrob Agents Chemother 33:915-919, 1989.
8. Baggot JD: Principles of Drug Disposition in Domestic Animals: The Basis of Veterinary Clinical Pharmacology. Philadelphia, WB Saunders Company, 1977.
9. Barlough JE, Ackley CD, George JW, et al: Acquired Immune Dysfunction In Cats With Experimentally Induced Feline Immunodeficiency Virus Infection: Comparison of Short-Term and Long-Term Infections. J Acquired Immune Defic Syndr 4:219-227, 1991.
10. Gregory CR, Taylor NJ, Willets NH, et al: Response to Isoantigens and Mitogens in the Cat: Effects of Cyclosporine A. Am J Vet Res 48:126-130, 1987.
11. Reubel G, George JW, Higgins J, et al: Effect of Chronic Feline Immunodeficiency Virus Infection on Experimental Feline Calicivirus-Induced Disease. Vet Microbiol 39:335-351, 1994.
12. Dua N, Reubel G, Higgins J, et al: The Primary Stage of Feline Immunodeficiency Virus Infection: Clinical, Hematologic and Virologic Features. Vet Immunol, in press, 1994.
13. Barlough JE, North TW, Oxford CL, et al: Feline Immunodeficiency Virus Infection of Cats as a Model to Test the Effect of Certain in vitro Selection Pressures on the Infectivity and Virulence of Resultant Lentivirus Variants. Antiviral Res 22:259-272, 1993.
14. + Ratio in Cats Experimentally Infected With Feline Immunodeficiency Virus. Vet Immunol Immunopathol 35:199-214, 1992.
15. Trainin Z, Ungar-Waron H, Essex M: Suppression of Humoral Antibody Response in Natural Retrovirus Infections. Science 220:858-859, 1983.
16. Skottner A, Clark RG, Fryklund L, et al: Growth Responses in a Mutant Dwarf Rat to Human Growth Hormone and Recombinant Human Insulin-Like Growth Factor 1. Endocrinology 124:2519-2526, 1989.
17. Haschek WM, Weigel RM, Scherba G, et al: Zidovudine Toxicity in Cats Infected With Feline Leukemia Virus. Fundam Appl Toxicol 14:764-775, 1990.